Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 · New England Journal of Medicine · 2,831 citations
https://doi.org/10.1056/nejmoa1009290
E
Elisabeth G.E. de Vries
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.7K
Papers
67.8K
Citations
121
h-index
803
i10-index
Elisabeth G.E. de Vries is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Radiopharmaceutical Chemistry and Applications & Medical Imaging Techniques and Applications & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 121, co-authored 1440 publications.
ORCID: 0000-0002-8949-7425Papers by this author
worksBiodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
2010 · Clinical Pharmacology & Therapeutics · 792 citations
https://doi.org/10.1038/clpt.2010.12
ESMO-Magnitude of Clinical Benefit Scale version 1.1
2017 · Annals of Oncology · 633 citations
https://doi.org/10.1093/annonc/mdx310
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
2019 · The Lancet Oncology · 549 citations
https://doi.org/10.1016/s1470-2045(19)30328-6
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
2022 · Nature Medicine · 403 citations
https://doi.org/10.1038/s41591-022-01695-5
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
2016 · JNCI Journal of the National Cancer Institute · 398 citations
https://doi.org/10.1093/jnci/djw192
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat